Search Results: Displaying all items (301)

First Author Title Journal Publication Date
Liu Q. Performance of interferon-γ release assay in the diagnosis of tuberculous lymphadenitis: a meta-analysis. PeerJ 2017
Narasimhan P. High rates of latent TB infection in contacts and the wider community in South India. Transactions of the Royal Society of Tropical Medicine and Hygiene 2017
Jeon Y. Diagnostic Utility of New Equation for Active Tuberculosis Based on Parameters of Interferon-γ Release Assay. Laboratory medicine 2017
Balkhy HH. Prevalence of Latent Mycobacterium Tuberculosis Infection (LTBI) in Saudi Arabia; Population based survey. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2017
Ruhwald M. Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6. Scientific reports 2017
Tanabe M. The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers. Internal medicine (Tokyo, Japan) 2017
Suárez I. Repurposing QuantiFERON for detection of neutralizing IFN-γ autoantibodies in patients with nontuberculous mycobacterial infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017
Moon HW. Evaluation of QuantiFERON®-TB Gold-Plus in Healthcare Workers in a Low-Incidence Setting. Journal of clinical microbiology 2017
Ruhwald M. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial. The Lancet. Respiratory medicine 2017
Little LM. The QuantiFERON-TB Gold In-Tube Assay in Neuro-Ophthalmology. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2017
Knierer J. QFT-Plus: a plus in variability? - Evaluation of new generation IGRA in serial testing of students with a migration background in Germany. Journal of occupational medicine and toxicology (London, England) 2017
De Groote MA. Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection. Journal of clinical microbiology 2017
Pathanapitoon K. Looking for Ocular Tuberculosis: Prevalence and Clinical Manifestations of Patients with Uveitis and Positive QuantiFERON(®)-TB Gold Test. Ocular immunology and inflammation 2016
Igari H. Quality control in QuantiFERON-TB gold in-tube for screening latent tuberculosis infection in health care workers. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2017
Sinha S. Comparison of quantiferon gold and Mantoux test in adults with serpiginous-like choroiditis in northern India. The National medical journal of India 2016
Hannoun D. Incidence of tuberculosis among children living in contact with smear-positive tuberculosis: Advantages and limits of the Quantiferon TB gold in tube test. International journal of mycobacteriology 2016
Lamberti M. Prevalence of latent tuberculosis infection in healthcare workers at a hospital in Naples, Italy, a low-incidence country. Journal of occupational medicine and toxicology (London, England) 2016
Kiazyk S. IFN- promoter polymorphisms do not affect QuantiFERON TB Gold In-Tube test results in a Canadian population. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2016
Mensah GI. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana. International journal of mycobacteriology 2017
Napoli C. Screening for Tuberculosis in Health Care Workers: Experience in an Italian Teaching Hospital. BioMed research international 2017
Load More Results